Sign In
Buy VRTX
$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
Where Will CRISPR Therapeutics Be in 1 Year?
03:00pm, Sunday, 31'st Jul 2022 The Motley Fool
The next 12 months could look very different from the past year for this biotech company.
My Top Stock to Buy If We're in a Recession
09:58am, Sunday, 31'st Jul 2022 The Motley Fool
This stock checks off all the boxes.
My Top Stock to Buy If We're in a Recession
05:58am, Sunday, 31'st Jul 2022
This stock checks off all the boxes.
2 Biotech Stocks That Could Help Make You a Fortune
10:15am, Saturday, 30'th Jul 2022 The Motley Fool
These companies have seen triple-digit revenue growth in recent years.
Vertex (VRTX) to Report Q2 Earnings: What's in the Cards?
07:51pm, Friday, 29'th Jul 2022 Zacks Investment Research
On Vertex Pharmaceuticals' (VRTX) Q2 earnings call, investors are most likely to focus on the sales performance of its cystic fibrosis (CF) medicines and updates on its non-CF pipeline candidates.
Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth
02:02pm, Thursday, 28'th Jul 2022 Zacks Investment Research
Vertex (VRTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AC Immune (ACIU) Reports Q2 Loss, Lags Revenue Estimates
12:45pm, Thursday, 28'th Jul 2022 Zacks Investment Research
AC Immune (ACIU) delivered earnings and revenue surprises of 0% and 100%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Missed Out on Vaccine Stocks? My Best Biotech Stock to Buy and Hold
10:00am, Thursday, 28'th Jul 2022 The Motley Fool
This company has 46 treatment programs in development.
CRISPR (CRSP) to Report Q2 Earnings: What's in the Cards?
04:19pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
On CRISPR Therapeutics' (CRSP) Q2 earnings call, investors will look for updates on its pipeline candidates, especially its lead candidate exa-cel.
Biotech Stock Roundup: BMY, BIIB's Q2 Earnings, GILD's Updates & More
03:15pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
Earnings updates from Bristol Myers (BMY) and Biogen (BIIB) are a few key highlights from the biotech sector during the past week.
Vertex Pharmaceuticals (VRTX) Gains As Market Dips: What You Should Know
09:45pm, Tuesday, 26'th Jul 2022 Zacks Investment Research
Vertex Pharmaceuticals (VRTX) closed the most recent trading day at $288.22, moving +1.6% from the previous trading session.
Should You Buy Beaten-Down Biotech Stocks & ETFs?
06:32pm, Tuesday, 26'th Jul 2022 Zacks Investment Research
We highlight 4 ETFs that have started rebounding after a brutal sell-off
This Stock Could Soar by Nearly 300%, Says Wall Street
02:07pm, Tuesday, 26'th Jul 2022 The Motley Fool
Are the Street's predictions too optimistic?
3 Winning Evergreen Stocks to Buy and Hold for the Next 25 Years
10:45am, Tuesday, 26'th Jul 2022 The Motley Fool
These companies have cornered the right markets and are chasing the right long-term trends.
Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?
10:20am, Tuesday, 26'th Jul 2022 Zacks Investment Research
Smart Beta ETF report for PBE
